Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: An observational study

Journal of Critical Care

Volumn 30, Issue 1, 2015, Pages 90-96

  Ostrowski, Sisse R ^a   Gaïni, Shahin ^b   Pedersen, Court ^b   Johansson, Pär I ^a,c  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Catecholamines; Endothelium; Infection; Sepsis; Syndecan 1; Thrombomodulin

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN; SYNDECAN 1; THROMBOMODULIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL RATE; ACUTE DISEASE; BLOOD; MIDDLE AGED; ORGAN DYSFUNCTION SCORE; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CATECHOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SYNDECAN-1; THROMBOMODULIN;

EID: 84920685384     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.10.006     Document Type: Article

References (56)

1. Angus D.C., van der P.T. Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
2. Levi M., van der P.T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34.
3. Levi M., van der P.T., Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol 2011, 34. 10.1007/s00281-011-0283-7.
4. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
5. Xing K., Murthy S., Liles W.C., Singh J.M. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit Care 2012, 16:R7.
6. Shapiro N.I., Trzeciak S., Hollander J.E., Birkhahn R., Otero R., Osborn T.M., et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009, 37:96-104.
7. Skibsted S., Jones A.E., Puskarich M.A., Arnold R., Sherwin R., Trzeciak S., et al. Biomarkers of endothelial cell activation in early sepsis. Shock 2013, 39:427-432.
8. Yin Q., Liu B., Chen Y., Zhao Y., Li C. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department. Thromb Res 2013, 132:471-476.
9. Cryer P.E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980, 303:436-444.
10. Dunser M.W., Hasibeder W.R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316.
11. Johansson P.I., Ostrowski S.R. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010, 75:564-567.
12. von Kanel R., Dimsdale J.E. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000, 65:357-369.
13. Lowenstein C.J., Morrell C.N., Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 2005, 15:302-308.
14. Van den B.G., de Zegher F., Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998, 83:1827-1834.
15. Vanhorebeek I., Langouche L., Van den B.G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2:20-31.
16. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013, 41:580-637.
17. Makhmudov R.M., Mamedov Y., Dolgov V.V., Repin V.S. Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa 1985, 27:456-463.
18. Kristova V., Kriska M., Canova R., Hejdova E., Kobzova D., Dobrocky P. Endothelial changes following repeated effect of vasoconstrictive substances in vitro. Acta Physiol Hung 1993, 81:363-370.
19. Hawkey C.M., Britton B.J., Wood W.G., Peele M., Irving M.H. Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 1975, 29:377-384.
20. van der P.T., Levi M., Dentener M., Jansen P.M., Coyle S.M., Braxton C.C., et al. Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997, 185:1143-1148.
21. Sefrin P. Catecholamines in the serum of multiple trauma patients-mediators of ARDS?. Prog Clin Biol Res 1987, 236:477-486.
22. Ostrowski S.R., Sorensen A.M., Larsen C.F., Johansson P.I. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med 2011, 19:64.
23. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777.
24. Becker B.F., Chappell D., Bruegger D., Annecke T., Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87:300-310.
25. Johansson P.I., Stensballe J., Rasmussen L.S., Ostrowski S.R. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 2012, 72:428-436.
26. Ostrowski S.R., Sørensen A.M., Windeløv N.A., Perner A., Welling K.L., Wanscher M., et al. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation. Scand J Trauma Resusc Emerg Med 2012, 20:27.
27. Ostrowski S.R., Berg R.M.G., Windeløv N.A., Plovsing R.R., Moller K., Johansson P.I. Coagulopathy, catecholamines and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis. A prospective study. J Crit Care 2013, 28:586-596.
28. Johansson P.I., Haase N., Perner A., Ostrowski S.R. Association between sympathoadrenal activation, fibrinolysis and endothelial damage in septic patients: a prospective study. J Crit Care 2014, 29:327-333.
29. Ostrowski S.R., Pedersen S.H., Jensen J.S., Mogelvang R., Johansson P.I. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 2013, 17:R32.
30. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906.
31. Blann A., Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc 1997, 17:3-11.
32. Blann A.D. Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?. Blood Coagul Fibrinolysis 2000, 11:623-630.
33. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991, 65:618-623.
34. Gaini S., Koldkjaer O.G., Pedersen C., Pedersen S.S. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53.
35. Gaini S., Pedersen S.S., Koldkaer O.G., Pedersen C., Moestrup S.K., Moller H.J. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol 2008, 151:423-431.
36. Gaini S., Koldkjaer O.G., Moller H.J., Pedersen C., Pedersen S.S. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care 2007, 11:R76.
37. Aird W.C. Endothelium as an organ system. Crit Care Med 2004, 32:S271-S279.
38. Salmon A.H., Satchell S.C. Endothelial glycocalyx dysfunction in disease: albuminuria and altered microvascular permeability. J Pathol 2012, 226:562-574.
39. Kozar R.A., Peng Z., Zhang R., Holcomb J.B., Pati S., Park P., et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011, 112:1289-1295.
40. Haywood-Watson R.J., Holcomb J.B., Gonzalez E.A., Peng Z., Pati S., Park P.W., et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One 2011, 6:e23530.
41. Hirase T., Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 2012, 302:H499-H505.
42. Johansson P.I., Stensballe J., Rasmussen L.S., Ostrowski S.R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011, 254:194-200.
43. Gando S., Nanzaki S., Morimoto Y., Kobayashi S., Kemmotsu O. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive Care Med 2000, 26:38-44.
44. Grundmann S., Fink K., Rabadzhieva L., Bourgeois N., Schwab T., Moser M., et al. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 2012, 83:715-720.
45. Faust S.N., Levin M., Harrison O.B., Goldin R.D., Lockhart M.S., Kondaveeti S., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345:408-416.
46. Marshall J.C. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001, 29:S99-S106.
47. Sallisalmi M., Tenhunen J., Yang R., Oksala N., Pettila V. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol Scand 2012, 56:316-322.
48. Johansson P.I., Sørensen A.M., Perner A., Welling K.L., Wanscher M., Larsen C.F., et al. Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets and leukocytes in response to increasing injury severity. Crit Care Med 2012, 40:1844-1850.
49. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009, 54:1747-1762.
50. Novotny N.M., Lahm T., Markel T.A., Crisostomo P.R., Wang M., Wang Y., et al. Beta-blockers in sepsis: reexamining the evidence. Shock 2009, 31:113-119.
51. Macchia A., Romero M., Comignani P.D., Mariani J., D'Ettorre A., Prini N., et al. Previous prescription of beta-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 2012, 40:2768-2772.
52. Leineweber K., Heusch G. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol 2009, 158:61-69.
53. de Montmollin E., Aboab J., Mansart A., Annane D. Bench-to-bedside review: beta-adrenergic modulation in sepsis. Crit Care 2009, 13:230.
54. Abboud I., Lerolle N., Urien S., Tadie J.M., Leviel F., Fagon J.Y., et al. Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status. Crit Care 2009, 13:R120.
55. Beloeil H., Mazoit J.X., Benhamou D., Duranteau J. Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br J Anaesth 2005, 95:782-788.
56. Ishii H., Majerus P.W. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985, 76:2178-2181.